Artificial Intelligence (AI) In Biopharmaceuticals Market Report 2026
Download Free Sample Buy Now
Artificial Intelligence (AI) In Biopharmaceuticals Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Artificial Intelligence (AI) In Biopharmaceuticals Market Report 2026

Global Outlook – By Offering (Hardware, Software, Services), By Deployment (Cloud, On-Premises), By Technology (Machine Learning, Natural Language Processing, Deep Learning, Other Technologies), By Application (Drug Discovery, Precision Medicine), By End-Users (Manufacturers, Contract Research Organizations, Academic And Government Research Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

• Artificial Intelligence (AI) In Biopharmaceuticals market size has reached to $2.1 billion in 2025

• Expected to grow to $8.77 billion in 2030 at a compound annual growth rate (CAGR) of 33.1%

• Growth Driver: Chronic Disease Prevalence Fueling Growth Of AI In Biopharmaceuticals Market

• Market Trend: Advancements In AI-Powered Solutions For Drug Discovery And Precision Medicine

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI) In Biopharmaceuticals Market?

Artificial intelligence (AI) in biopharmaceuticals refers to applying various AI techniques to analyze complex biological data and improve various aspects of drug discovery, development, and delivery within the pharmaceutical industry. AI in biopharmaceuticals holds great promise for revolutionizing drug discovery, development, and delivery processes by accelerating timelines, reducing costs, and improving the efficiency and effectiveness of treatments.

The main types of offerings in artificial intelligence (AI) in biopharmaceuticals are hardware, software, and services. Hardware refers to the physical components of a computer system, including devices such as memory, disk drives, controllers, and specialized software like database management systems. It includes various deployments, including cloud and on-premises, and the technologies used are machine learning, natural language processing, and deep learning, as well as applications used in business processes and supply chains, drug discovery, medical imaging and diagnostics, and precision medicine, end users are manufacturers, contract research organizations, and academic and government research institutes.

Artificial Intelligence (AI) In Biopharmaceuticals Market Global Report 2026 Market Report bar graph

What Is The Artificial Intelligence (AI) In Biopharmaceuticals Market Size and Share 2026?

The artificial intelligence (ai) in biopharmaceuticals market size has grown exponentially in recent years. It will grow from $2.1 billion in 2025 to $2.79 billion in 2026 at a compound annual growth rate (CAGR) of 33.0%. The growth in the historic period can be attributed to early adoption of ai in pharma research, increasing computational power, rising investment in biopharmaceutical r&d, integration of omics data, growth of cloud-based data storage.

What Is The Artificial Intelligence (AI) In Biopharmaceuticals Market Growth Forecast?

The artificial intelligence (ai) in biopharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $8.77 billion in 2030 at a compound annual growth rate (CAGR) of 33.1%. The growth in the forecast period can be attributed to advancements in machine learning algorithms, expansion of ai-enabled lab equipment, increased adoption of predictive analytics, rise in collaborative ai-biopharma platforms, government incentives for ai-driven healthcare. Major trends in the forecast period include ai-driven drug discovery, predictive analytics for clinical trials, automation in laboratory processes, real-world data integration, personalized treatment optimization.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Artificial Intelligence (AI) In Biopharmaceuticals Market Segmentation

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Drug Discovery, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

What Is The Driver Of The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The growing prevalence of chronic diseases is expected to propel the growth of artificial intelligence (AI) in biopharmaceuticals market going forward. Chronic diseases are long-lasting conditions that generally progress slowly and may persist for years or even a lifetime. It arises from lifestyle factors, an aging population, genetic predispositions, and environmental factors. AI in biopharmaceuticals is increasingly used to manage chronic diseases because it analyzes large volumes of diverse data sources, identifies patterns, and personalizes treatment approaches. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency. in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the growing prevalence of chronic diseases drives the growth of artificial intelligence (AI) in the biopharmaceuticals market.

Key Players In The Global Artificial Intelligence (AI) In Biopharmaceuticals Market

Major companies operating in the artificial intelligence (ai) in biopharmaceuticals market are Exscientia Limited, DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Global Artificial Intelligence (AI) In Biopharmaceuticals Market Trends and Insights

Major companies operating in artificial intelligence (AI) in biopharmaceuticals focus on developing innovative advancements such as target and lead identification suite AI-powered solutions to accelerate drug discovery and precision medicine to transform life sciences organizations. These solutions for drug discovery and precision medicine encompass a variety of innovative approaches to developing new drugs and tailoring treatments to individual patients. For instance, in May 2023, Google LLC, a US-based provider of cloud computing services, launched two new AI-powered tools called target and lead identification suites, designed to help researchers predict and understand the structure of proteins, which is a fundamental part of drug development. Additionally, this suite will help researchers ingest, store, analyze, and share mass amounts of genomic data, which is crucial for precision medicine. Also, these tools aim to streamline the drug discovery process, reduce costs, and bring new treatments to market faster. By providing efficient data management, accurate predictions of protein structures, and advanced genomic analysis capabilities, these tools aim to revolutionize drug development processes and improve patient outcomes.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

In February 2023, ZS Associates, a US-based management consulting and technology firm, acquired Trials.ai Inc. for an undisclosed amount. With this acquisition, Associates aims to enhance design processes within the pharmaceutical industry by leveraging artificial intelligence (AI) to optimize speed, improve participant experiences, and expedite the delivery of pharmaceutical therapies to the market. Trials.ai Inc. is a US-based company that focuses on revolutionizing clinical trials through artificial intelligence (AI) and machine learning (ML) technologies.

Regional Insights

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI) In Biopharmaceuticals Market?

The artificial intelligence (AI) in biopharmaceuticals market consists of revenues earned by entities by services such as drug discovery, personalized medicine analytics, clinical trial optimization, healthcare decision support, and data integration and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in biopharmaceuticals market also includes of sales of decision support System, predictive modeling tools, robotics, and automation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence (AI) In Biopharmaceuticals Market Report 2026?

The artificial intelligence (ai) in biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai) in biopharmaceuticals industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Artificial Intelligence (AI) In Biopharmaceuticals Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.79 billion
Revenue Forecast In 2035 $8.77 billion
Growth Rate CAGR of 33.0% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Offering, Deployment, Technology, Application, End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Exscientia Limited, DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) In Biopharmaceuticals Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) In Biopharmaceuticals Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Biotechnology, Genomics & Precision Medicine

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Ai-Driven Drug Discovery

4.2.2 Predictive Analytics For Clinical Trials

4.2.3 Automation In Laboratory Processes

4.2.4 Real-World Data Integration

4.2.5 Personalized Treatment Optimization

5. Artificial Intelligence (AI) In Biopharmaceuticals Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Firms

5.3 Contract Research Organizations

5.4 Academic Research Institutes

5.5 Government Research Institutes

6. Artificial Intelligence (AI) In Biopharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) In Biopharmaceuticals Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Artificial Intelligence (AI) In Biopharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Size, Comparisons And Growth Rate Analysis

7.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) In Biopharmaceuticals Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) In Biopharmaceuticals Market Segmentation

9.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hardware, Software, Services

9.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cloud, On-Premises

9.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

9.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Discovery, Precision Medicine

9.5. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

9.6. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

9.7. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Discovery Platforms, Predictive Analytics Tools, Natural Language Processing Solutions

9.8. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

10. Artificial Intelligence (AI) In Biopharmaceuticals Market Regional And Country Analysis

10.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market

11.1. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI) In Biopharmaceuticals Market

12.1. China Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI) In Biopharmaceuticals Market

13.1. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market

14.1. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market

15.1. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market

16.1. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market

17.1. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI) In Biopharmaceuticals Market

18.1. Taiwan Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI) In Biopharmaceuticals Market

19.1. South East Asia Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market

20.1. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI) In Biopharmaceuticals Market

21.1. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market

22.1. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI) In Biopharmaceuticals Market

23.1. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market

24.1. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market

25.1. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market

26.1. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market

27.1. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI) In Biopharmaceuticals Market

28.1. North America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI) In Biopharmaceuticals Market

29.1. USA Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market

30.1. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI) In Biopharmaceuticals Market

31.1. South America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market

32.1. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market

33.1. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market

34.1. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Segmentation By Deployment, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI) In Biopharmaceuticals Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape And Company Profiles

36.1. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Artificial Intelligence (AI) In Biopharmaceuticals Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Artificial Intelligence (AI) In Biopharmaceuticals Market Company Profiles

36.3.1. Exscientia Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.2. DeepMind Technologies Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Schrödinger Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. XtalPi Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. ConcertAI Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI) In Biopharmaceuticals Market Other Major And Innovative Companies

Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

38. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Biopharmaceuticals Market

40. Artificial Intelligence (AI) In Biopharmaceuticals Market High Potential Countries, Segments and Strategies

40.1 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2030 - Countries Offering Most New Opportunities

40.2 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2030 - Segments Offering Most New Opportunities

40.3 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Overview Of Key Products - Product Examples
  • Table 2: Global Artificial Intelligence (AI) In Biopharmaceuticals Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Supply Chain Analysis
  • Table 4: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major Raw Material Providers
  • Table 5: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major Resource Providers
  • Table 6: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major Manufacturers (Suppliers)
  • Table 7: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major Distributors And Channel Partners
  • Table 8: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Key Technologies & Future Trends
  • Table 9: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major Trends
  • Table 10: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major End Users
  • Table 11: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Artificial Intelligence (AI) In Biopharmaceuticals Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Artificial Intelligence (AI) In Biopharmaceuticals Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Artificial Intelligence (AI) In Biopharmaceuticals Market - TAM, US$ Billion, 2025
  • Table 15: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Artificial Intelligence (AI) In Biopharmaceuticals Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Artificial Intelligence (AI) In Biopharmaceuticals Market - Company Scoring Matrix
  • Table 99: Exscientia Limited Financial Performance
  • Table 100: DeepMind Technologies Limited Financial Performance
  • Table 101: Schrödinger Inc. Financial Performance
  • Table 102: XtalPi Inc. Financial Performance
  • Table 103: ConcertAI Inc. Financial Performance
  • Table 104: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Competitive Dashboard
  • Table 106: Global Artificial Intelligence (AI) In Biopharmaceuticals Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Artificial Intelligence (AI) In Biopharmaceuticals Market Size Gain ($ Billion), Segmentation By Offering, 2025 – 2030
  • Table 108: Global, Artificial Intelligence (AI) In Biopharmaceuticals Market Size Gain ($ Billion), Segmentation By Deployment, 2025 – 2030
  • Table 109: Global, Artificial Intelligence (AI) In Biopharmaceuticals Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

List Of Figures

    Figure 1: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Artificial Intelligence (AI) In Biopharmaceuticals Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Supply Chain Analysis
  • Figure 4: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major Raw Material Providers
  • Figure 5: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major Resource Providers
  • Figure 6: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major Distributors And Channel Partners
  • Figure 8: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Key Technologies & Future Trends
  • Figure 9: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major Trends
  • Figure 10: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Major End Users
  • Figure 11: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Artificial Intelligence (AI) In Biopharmaceuticals Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Artificial Intelligence (AI) In Biopharmaceuticals Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Artificial Intelligence (AI) In Biopharmaceuticals Market - TAM, US$ Billion, 2025
  • Figure 15: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Artificial Intelligence (AI) In Biopharmaceuticals Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Artificial Intelligence (AI) In Biopharmaceuticals Market - Company Scoring Matrix
  • Figure 99: Exscientia Limited Financial Performance
  • Figure 100: DeepMind Technologies Limited Financial Performance
  • Figure 101: Schrödinger Inc. Financial Performance
  • Figure 102: XtalPi Inc. Financial Performance
  • Figure 103: ConcertAI Inc. Financial Performance
  • Figure 104: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Competitive Dashboard
  • Figure 106: Global Artificial Intelligence (AI) In Biopharmaceuticals Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Artificial Intelligence (AI) In Biopharmaceuticals Market Size Gain ($ Billion), Segmentation By Offering, 2025 – 2030
  • Figure 108: Global, Artificial Intelligence (AI) In Biopharmaceuticals Market Size Gain ($ Billion), Segmentation By Deployment, 2025 – 2030
  • Figure 109: Global, Artificial Intelligence (AI) In Biopharmaceuticals Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Global Oncology Precision Medicine Market Landscape: Trends and Market Share to 2029

Read More About Global Oncology Precision Medicine Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Oral Antidiabetic Drugs Industry Through 2029

Read More About Competitive and Market Trend Analysis of Oral Antidiabetic Drugs Industry Through 2029

Key Market Drivers, Trends, and Forecast for the Global Orally Disintegrating Tablet Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Orally Disintegrating Tablet Industry

Global Insights: Over-The-Counter (OTC) Artificial Tears Market Expected to Surpass $6.19 Billion by 2029

Read More About Global Insights: Over-The-Counter (OTC) Artificial Tears Market Expected to Surpass $6.19 Billion by 2029

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Read More About Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Tax Management Market 2023 – By Component (Software, Services), By Deployment Mode (Cloud, On-Premises), By Vertical (Corporate Banking Financial Services And Insurance (BFSI), Information Technology (IT) And Telecom, Ma...

Energy Efficient Devices Market Report 2026 - Global Outlook – By Component (Hardware, Software, Services), By System Type (Industrial Energy Management Systems (IEMS), Building Energy Management Systems (BEMS), Home Ene...

AI In Pharma Market Report 2026 - Global Outlook – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Di...

Virtual Kitchen Market Report 2026 - Global Outlook – By Component (Software, Services, Hardware, Other Components), By Application (Workplaces, Schools, Other Applications), By End-User (Commercial Space, Hospitality, O...

Neuralgia Treatment Market Report 2026 - Global Outlook – By Treatment (Drug-Based, Surgeries), By Indication (Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia...

Embedded Field-Programmable Gate Array (FPGA) Market Report 2026 - Global Outlook – By Type ( Electrically Erasable Programmable Read-Only Memory, Antifuse, Static Random Access Memory, Other Types), By Technology ( Very...

Artificial Intelligence (AI) In Drug Discovery Market Report 2026 - Global Outlook – By Technology (Context-Aware Processing, Natural Language Processing, Deep Learning), By Drug Type (Small Molecules, Large Molecules), ...

Frequently Asked Questions

The Artificial Intelligence (AI) In Biopharmaceuticals market was valued at $2.1 billion in 2025, increased to $2.79 billion in 2026, and is projected to reach $8.77 billion by 2030.

The global Artificial Intelligence (AI) In Biopharmaceuticals market is expected to grow at a CAGR of 33.1% from 2026 to 2035 to reach $8.77 billion by 2035.

Some Key Players in the Artificial Intelligence (AI) In Biopharmaceuticals market Include, Exscientia Limited, DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentA

Major trend in this market includes: Advancements In AI-Powered Solutions For Drug Discovery And Precision Medicine. For further insights on this market. request a sample here

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligen

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us